ArticleCancer immunology, immunotherapy : CII2025

GD2-CAR NK-92 cell activity against neuroblastoma cells is insusceptible to TIGIT knockout.

Wiebke Jünemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.